GNMX holdings: all 57 positions
GNMX held 57 positions as of Oct 14, 2026. Moderna Inc is the largest at 10.29%; the top 10 are 48.6% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Moderna Inc | MRNA | 10.29% |
| 2 | Thermo Fisher Scientific Inc | TMO | 8.85% |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 5.73% |
| 4 | Illumina Inc | ILMN | 4.91% |
| 5 | Guardant Health Inc | GH | 3.48% |
| 6 | Revolution Medicines Inc | RVMD | 3.29% |
| 7 | 10X Genomics Inc | TXG | 3.24% |
| 8 | Iovance Biotherapeutics Inc | IOVA | 3.17% |
| 9 | Genmab A/S | GMAB | 3.07% |
| 10 | Incyte Corp | INCY | 2.57% |
| 11 | Twist Bioscience Corp | TWST | 2.52% |
| 12 | Alnylam Pharmaceuticals Inc | ALNY | 2.46% |
| 13 | GRAIL Inc | GRAL | 2.30% |
| 14 | Bio-Techne Corp | TECH | 2.18% |
| 15 | Qiagen N.V. | QGEN | 1.95% |
| 16 | CareDx Inc | CDNA | 1.91% |
| 17 | BioMarin Pharmaceutical Inc | BMRN | 1.90% |
| 18 | Krystal Biotech Inc | KRYS | 1.81% |
| 19 | Tempus AI Inc | TEM | 1.76% |
| 20 | Adaptive Biotechnologies Corp | ADPT | 1.66% |
| 21 | NeoGenomics Inc | NEO | 1.35% |
| 22 | Caris Life Sciences Inc | CAI | 1.33% |
| 23 | Arrowhead Pharmaceuticals Inc | ARWR | 1.31% |
| 24 | CRISPR Therapeutics AG | CRSP | 1.29% |
| 25 | Veracyte Inc | VCYT | 1.26% |
| 26 | Schrodinger Inc/United States | SDGR | 1.25% |
| 27 | Personalis Inc | PSNL | 1.24% |
| 28 | Nurix Therapeutics Inc | NRIX | 1.17% |
| 29 | Ideaya Biosciences Inc | IDYA | 1.15% |
| 30 | Ionis Pharmaceuticals Inc | IONS | 1.12% |
| 31 | Absci Corp | ABSI | 1.04% |
| 32 | Relay Therapeutics Inc | RLAY | 0.94% |
| 33 | Azenta Inc | AZTA | 0.92% |
| 34 | Recursion Pharmaceuticals Inc | RXRX | 0.87% |
| 35 | Certara Inc | CERT | 0.85% |
| 36 | Beam Therapeutics Inc | BEAM | 0.83% |
| 37 | uniQure NV | QURE | 0.78% |
| 38 | Sarepta Therapeutics Inc | SRPT | 0.77% |
| 39 | Castle Biosciences Inc | CSTL | 0.76% |
| 40 | GeneDx Holdings Corp | WGS | 0.75% |
| 41 | Intellia Therapeutics Inc | NTLA | 0.67% |
| 42 | 4D Molecular Therapeutics Inc | FDMT | 0.63% |
| 43 | Generate Biomedicines Inc | GENB | 0.58% |
| 44 | Pacific Biosciences of California Inc | PACB | 0.58% |
| 45 | Ultragenyx Pharmaceutical Inc | RARE | 0.56% |
| 46 | Biodesix Inc | BDSX | 0.55% |
| 47 | Sophia Genetics SA | SOPH | 0.55% |
| 48 | Fulgent Genetics Inc | FLGT | 0.54% |
| 49 | Arcturus Therapeutics Holdings Inc | ARCT | 0.44% |
| 50 | Myriad Genetics Inc | MYGN | 0.40% |
| 51 | Solid Biosciences Inc | SLDB | 0.38% |
| 52 | Prime Medicine Inc | PRME | 0.37% |
| 53 | Editas Medicine Inc | EDIT | 0.29% |
| 54 | Standard BioTools Inc | LAB | 0.27% |
| 55 | Rocket Pharmaceuticals Inc | RCKT | 0.26% |
| 56 | Precision BioSciences Inc | DTIL | 0.25% |
| 57 | Caribou Biosciences Inc | CRBU | 0.07% |
| First American Government Obligations Fund 12/01/2031 | 2.59% | ||
| Cash and other net assets | −0.01% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of GNMX, data as of Oct 14, 2026. https://etfiq.com/funds/gnmx/holdings/
ETFIQ. (Oct 14, 2026). Holdings of GNMX. Retrieved from https://etfiq.com/funds/gnmx/holdings/
[Holdings of GNMX (ETFIQ, Oct 14, 2026)](https://etfiq.com/funds/gnmx/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.